Company: TVRD
Filing Date: 2025-02-14
Form Type: S-4/A
Source: 0001104659-25-013053
Chunk: 871

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-02-14
Form: S-4/A
Chunk 871
---
 In February 2021, 2,772 of these restricted stock units vested and were settled in shares of the Company’s common stock in satisfaction of the first year of vesting. For the years ended December 31, 2023, 2022 and 2021, the Company recognized $39, $526 and $607 of stock compensation expense associated with these awards, with $26 recorded in R&D expense and $13 in G&A expense for the 2023 period, $175 recorded in R&D expense and $351 in G&A expense for the 2022 period, and $174 recorded in R&D expense and $433 recorded in G&A expense for the 2021 period. G&A amounts recorded for the years ended December 31, 2022 and 2021 included $264 and $73, respectively, of stock compensation expense relating to the modification of certain of these restricted stock units on November 1, 2021 (see Stock Award Modifications below). As of December 31, 2023, none of these restricted stock units were outstanding as these restricted stock units were fully vested in February 2023.

A summary of restricted stock unit activity related to employees and non-employee members of the Company’s Board of Directors as of and for the year ended December 31, 2023 is as follows:

<div align='center'>F-77</div>

TABLE OF CONTENTS

CARA THERAPEUTICS, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(amounts in thousands, except share and per share data)

| ​                                                                           | ​ | ​ | Number ofUnits |   |         |   | ​ | ​ | WeightedAverage GrantDate Fair Value |   |        |   | ​ |
|:----------------------------------------------------------------------------|:--|:--|:---------------|:--|--------:|:--|:--|:--|:-------------------------------------|:--|-------:|:--|:--|
| Outstanding, December 31, 2022                                              | ​ | ​ | ​              | ​ |  31,043 | ​ | ​ | ​ | ​                                    | $ | 158.40 | ​ | ​ |
| Awarded                                                                     | ​ | ​ | ​              | ​ |  50,098 | ​ | ​ | ​ | ​                                    | ​ |  93.72 | ​ | ​ |
| Vested and released                                                         | ​ | ​ | ​              | ​ | -16,939